AI assistant
ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2016
Jun 27, 2016
33148_dirs_2016-06-27_79d0a2ad-d510-4728-8eaf-b8e277613d5f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INOTEK PHARMACEUTICALS CORP (ITEK)
CIK: 0001281895
Period of Report: 2016-06-23
Reporting Person: HOWES PAUL G (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-06-23 | Stock Options (Right to Buy) | $7.61 | A | 12000 | Acquired | 2026-06-22 | Common Stock (12000) | Direct |
Footnotes
F1: The stock option award was issued pursuant to Inotek Pharmaceuticals Corporation's 2014 Stock Option and Incentive Plan. The option grant shall vest in equal quarterly installments at the end of each quarter following June 23, 2016, subject to continued service through such dates.
F2: As previously reported on June 26, 2015, Reporting Person was granted a stock option award under the Plan. The total beneficially owned derivative securities following the grant inadvertently included securities of a separate class, and, accordingly, such previously reported shares are now properly excluded.